aurobindo pharma
- K
Aurobindo Pharma Shares Rise 2% After USFDA Final Approval for Everolimus Tablets
Shares of Aurobindo Pharma Ltd. gained as much as 2% on Thursday, February 26, after the company announced that its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration for Everolimus Tablets.The approval allows Eugia Unit I to...- Karthik
- Thread
- anda approval aurobindo pharma eugia pharma specialities european revenue growth everolimus tablets generic drugs iqvia market data kidney transplant liver transplant oncology drugs organ transplantation pharmaceutical manufacturing pharmaceutical sales research and development us food and drug administration
- Replies: 0
- Forum: Stocks
- K
Pharma Sector Revival: Analyst Picks Zydus, Sun Pharma, Aurobindo
After nearly two years of sustained correction in pharmaceutical stocks, valuations across the sector have eased to more reasonable levels, prompting Elara Securities to adopt a constructive stance on select names within the space.Elara’s Preferred Pharma Picks Elara Securities has identified... - K
Aurobindo Pharma to Boost Penicillin G Output Beyond 10,000 MT Annually, Targets 20 to 21% EBITDA Margin in FY26
Penicillin G Expansion Gains Momentum in Kakinada SEZ Aurobindo Pharma is stepping up its Penicillin G production, with plans to manufacture more than 10,000 metric tonnes annually over the next 12 months, according to Chief Financial Officer S Subramanian.The Hyderabad-based pharmaceutical...